Lv41
630 积分 2025-04-14 加入
Pulmonary arterial hypertension treatment. A new era
1个月前
已关闭
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
1个月前
已完结
Pulmonary arterial hypertension
1个月前
已完结
Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review
1个月前
已完结
A phase 1, single-center, open-label, dose-rising clinical trial to evaluate the pharmacokinetics, safety and tolerability of treprostinil inhalation powder (TreT) in healthy normal volunteers
2个月前
已关闭
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
2个月前
已完结
The race to reset autoimmune diseases
2个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
2个月前
已完结
Efficacy and safety of dotinurad versus febuxostat for the treatment of gout: a randomised, multicentre, double-blind, phase 3 trial in China
2个月前
已完结
皖公网安备34019202002308
